Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
stimulated mesenchymal stem cells
- Development stage
- Unknown
- Lead developer
- Acıbadem Labcell
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intralesional
01
Overview
Stimulated mesenchymal stem cells (MSCs) are an advanced cell therapy product developed by Acıbadem Labcell. These cells are mesenchymal stem cells that have been 'primed' or 'activated' in vitro—typically through exposure to specific cytokines (such as IFN-gamma or TNF-alpha) or specialized culture conditions—to enhance their therapeutic potency. This stimulation is designed to augment the cells' natural immunomodulatory and regenerative capabilities, increasing the secretion of anti-inflammatory factors and growth factors. While Acıbadem Labcell lists these cells as part of their manufacturing and R&D service portfolio, they are intended for use in treating conditions characterized by excessive inflammation or tissue damage, leveraging the cells' ability to home to injury sites and modulate the local microenvironment.
- Other names
- uyarılmış mezenkimal kök hücrelerStimulated Mesenchymal Stem CellsStimulated MSCActivated Mesenchymal Stem Cells
Beyond the preview
Go deeper on stimulated mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on stimulated mesenchymal stem cells.